10x Genomics, Inc. (LON:0A88)
13.56
-0.09 (-0.67%)
At close: Nov 3, 2025
10x Genomics Revenue
10x Genomics had revenue of $172.91M USD in the quarter ending June 30, 2025, with 12.93% growth. This brings the company's revenue in the last twelve months to $644.47M, up 2.02% year-over-year. In the year 2024, 10x Genomics had annual revenue of $610.79M, down -1.28%.
Revenue (ttm)
$644.47M
Revenue Growth
+2.02%
P/S Ratio
2.74
Revenue / Employee
$493.47K
Employees
1,306
Market Cap
1.29B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 610.79M | -7.94M | -1.28% |
| Dec 31, 2023 | 618.73M | 102.32M | 19.81% |
| Dec 31, 2022 | 516.41M | 25.92M | 5.28% |
| Dec 31, 2021 | 490.49M | 191.65M | 64.13% |
| Dec 31, 2020 | 298.85M | 52.95M | 21.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 140.08B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |